DNLI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Denali Therapeutics Inc

Watchlist Manager

Watchlist

Price: 22.29 USD -2.24% Market Closed

Market Cap: $3.5B

	Denali Therapeutics Inc NASDAQ:DNLI	US
	Virgin Money UK PLC OTC:CYBBF	UK
	MSP Steel & Power Ltd NSE:MSPL	IN
E	Eureka Design PCL SET:UREKA	TH
	BREMER LAGERHAUS-GESELLSCHAFT AG von 1877 F:BLH	DE
	Pool Corp NASDAQ:POOL	US
	Denison Mines Corp TSX:DML	CA
S	Sonae - SGPS SA ELI:SON	PT
	Zijin Mining Group Co Ltd SSE:601899	CN
B	Bloom Energy Corp F:1ZB	US
	Cipherpoint Ltd ASX:CPT	AU
	Baosheng Media Group Holdings Ltd NASDAQ:BAOS	CN
T	Tata Motors Ltd BSE:570001	IN
D	Development Investment Construction JSC VN:DIG	VN
	Tyman PLC F:LUO1	UK

Profitability Summary

Denali Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

97%

Sustainable 3Y Average Gross Margin

19%

Negative Operating Margin

-15 058%

Negative 3Y Average Operating Margin

-10 673%

Declining Operating Margin

-48% > -15 058%

Negative Net Margin

-14 191%

Negative 3Y Average Net Margin

-9 320%

Declining Net Margin

-37% > -14 191%

Negative Free Cash Flow Margin

-12 937%

Negative 3Y Average Free Cash Flow Margin

-8 848%

Declining Free Cash Flow Margin

-94% > -12 937%

Negative ROE

-55%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-134%

Declining ROIC

-101% > -157%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.